A series of seven BODIPYs functionalized with ortho-carborane groups at the 8(meso) or 3/5(α) position were synthesized and characterized by NMR, HRMS, HPLC, and in the cases of 2b and 5b, by X-ray analysis. The BODIPYs exhibited low dark toxicity and phototoxicity toward human glioma T98G cells, and their cellular uptake varied significantly, with 5b accumulating the most and 7 the least. All BODIPYs localized mainly within the cell ER. The BODIPYs showed higher permeabilities than lucifer yellow across human hCMEC/D3 brain endothelial cell monolayers as the BBB model. Among this series, 1b showed the highest BBB permeability (P e = 16.4 × 10 −5 cm/s), probably as a result of its lower MW (366 Da) and favorable hydrophobicity (log P = 1.5).
INTRODUCTION
Boron neutron capture therapy (BNCT) is a very promising binary anticancer methodology, especially for the treatment of brain tumors because it can selectively target and destroy malignant cells in the presence of healthy normal cells. 1 -3 BNCT involves the irradiation of nonradioactive 10 B-containing tumors with low-energy thermal neutrons, causing the excitation of 10 B to 11 B, which rapidly produces cytotoxic high linear energy transfer (high-LET) α and 7 Li particles, γ radiation, and about 2.4 MeV of kinetic energy through a nuclear fission reaction. The generated high-LET particles have short path lengths of less than 10 μm in tissue, therefore restricting the damage to 10 B-containing tumor cells. Furthermore, biologically abundant nuclei including 12 C, 1 H, and 14 N possess very small nuclear cross sections, thus posing little interference with the 10 B(n,α) 7 Li capture reaction. Another advantage of BNCT is that thermal and epithermal neutrons are able to penetrate deep into tissues to reach deep-seated tumors. However, a relatively high boron tumor concentration of at least 20 μg 10 B/g tumor is required for effective BNCT treatment, and this has driven recent research in the areas of boron drug development and delivery methodologies for BNCT.
BNCT has been applied for the treatment of high-grade brain tumors, such as glioblastoma multiforme (GBM), and other difficult-to-treat malignancies, including melanomas and recurrent head and neck cancers. 3 -5 One major challenge in the BNCT modality for brain tumors arises from the existence of the blood-brain barrier (BBB) that prevents most drugs from penetrating into the brain and from reaching the targeted tumor cells. 6 -11 The BBB permeability of drugs has been shown to be related to the physicochemical properties of the drugs, including their lipophilic character, molecular weight (MW), size, polar surface area, charge, and extent of ionization. 12 -14 Among these, the two main characteristics in a small molecule that favor its crossing of the BBB by passive diffusion are (1) molecular weight under 500 Da and (2) high lipophilic character, usually measured by the octanol-water partition coefficient, log P < 5.
6 , 12 -14 Although significant hydrophobicity is important for enhanced permeability across the BBB, BNCT drugs also need to be soluble in aqueous media to enable their systemic administration. 2 Therefore, there is continued need to develop amphiphilic compounds as boron delivery drugs for BNCT of brain tumors, with appropriate balance between hydrophilicity and lipophilicity, as well as molecular weight of <500 Da for efficient BBB permeability and tumor cell uptake.
Two boron-containing drugs of low molecular weight have been extensively used in BNCT clinical trials: the sodium salt of the sulfhydryl boron hydride Na 2 B 12 H 11 SH (BSH) and L-4-dihydroxyborylphenylalanine (BPA). 3 -5 Although BSH and BPA have demonstrated efficacy in BNCT clinical trials, they have very limited BBB permeability. 10 , 15 Other boronated compounds have been investigated as potential BNCT drugs, including amino acids, peptides, carbohydrates, nucleosides, liposomes, porphyrins, and monoclonal antibodies (mAbs). 2 , 7 Among these, particularly promising are mAbs due to their very high specificity for a tumor-associated epitope, and porphyrin derivatives due to their ability to transport large amounts of boron within cells. However, these BNCT agents have limited BBB crossing ability, mainly due to their large size, high molecular weight, and hydrophobicity.
, 15
We have recently investigated the BBB permeability of a series of carboranylporphyrins conjugated to polyamines, glucose, arginine, and an opioid peptide, 16 but they all showed low permeabilities (P e < 3.3 × 10 −6 cm/s) across hCMEC/D3 cell monolayers 17 -19 as the BBB model. On the other hand, amphiphilic boron dipyrromethene (BODIPY) compounds of low molecular weight could show enhanced permeability and promise as boron delivery drugs for BNCT. 20 BODIPY dyes have attracted special interest in recent years due to their various applications in biological labeling, drug delivery, imaging, sensing, and theranostics. 21 -24 BODIPYs are strongly UV-vis absorbing and generally emit sharp fluorescence with high quantum yields, which can facilitate detection and quantification of tissue-localized boron in BNCT. BODIPYs have also shown negligible sensitivity toward solvent polarity and solution pH, high permeability across cellular membranes, and relatively high stability under physiological conditions.
BODIPYs functionalized with carborane clusters have been prepared via Suzuki 20 and Sonogashira 25 cross-coupling reactions of the corresponding 2,6-diiodo-substituted compounds. Alternatively, carboranes can be introduced onto the BODIPY at the 3(5)-and/or 8-positions through substitution reactions on the corresponding chlorinated derivatives. 20 , 26 , 27 Herein we report the synthesis of a series of seven carboranyl-BODIPYs from the corresponding chloro-BODIPY derivatives, with molecular weights in the range 366-527 Da and log P in the range 1.5-2.7. The cytotoxicity and uptake of the BODIPYs in human glioma T98G cells, as well as their permeability across the BBB using hCMEC/D3 cells, were investigated and compared.
EXPERIMENTAL SECTION

Synthesis
All the chemicals and reagents were purchased from Sigma-Aldrich and Fisher Scientific and used as received. 27 and 7 27 were synthesized as previously reported.
General Procedure for Synthesis of BODIPYs via Nucleophilic Substitution
Reaction-The starting chloro-BODIPY (0.05 mmol) was dissolved in 2 mL of THF. 1-Mercapto-1,2-carborane (0.055 mmol) and K 2 CO 3 (0.5 mmol) were added, and the final mixture was stirred at room temperature. TLC was used to monitor the reaction until completion (2-5 h). The crude solid product was filtered and purified by column chromatography or preparative TLC using CH 2 Cl 2 /hexanes or ethyl acetate/hexanes for elution. 
Spectroscopic Studies
UV-visible and fluorescence spectra were collected on a PerkinElmer Lambda 35 UV/vis spectrometer and PerkinElmer LS 55 luminescence spectrometer at room temperature. Quartz cuvettes (10 mm path length) and spectroscopic grade solvents were used for both measurements. Optical density (ε) was determined by using the solutions with absorbance at λ max (0.5-1). Quantum yields were determined by using the dilute solutions with absorbance (0.04-0.06) at the particular excitation wavelength. Cresyl violet perchlorate (0.54 in methanol) and rhodamine 6G in ethanol (0.95) were used as external standards for the carboranyl BODIPYs 5b, 6b, and 1b-3b, 4, 7, respectively. The relative fluorescence quantum yields (Φ f ) were determined by calculations using the following equation, where Φ stands for fluorescence quantum yields, n stands for refractive indexes, F stands for the areas under the emission peaks, A stands for absorbance at the particular excitation wavelength, and subscripts X and R refer to the tested and standard samples, respectively.
Crystallography
X-ray data for 2b and 5b were collected at 
Octanol-Water Partition Coefficients
The partition coefficients (log P) were measured by adapting a reported procedure. 31 
1-
Octanol and Milli-Q water were mutually saturated, and the two phases were separated. A 64 μM stock solution was prepared by dissolving the BODIPY into water-saturated 1-octanol. Then 2 mL of the stock solution was added to 6 mL of Milli-Q water in a 15 mL volumetric tube and the mixture was intensively vortexed for 10 min. After complete separation of the two phases, an aliquot from the 1-octanol layer was diluted with watersaturated 1-octanol and its absorbance was recorded with a Varian Cary 50 Bio UV-vis spectrophotometer with a 10 mm path length quartz cuvette. The log P values were calculated as follows:
where A 0 and A oct are the absorbance of the compound in the water-saturated octanol before and after partitioning; V w and V O are the water and 1-octanol volumes, respectively.
Cell Studies
The T98G cell line used in this study was purchased from ATCC and cultured in ATCCformulated Eagle's minimum essential medium containing 10% FBS and 1% antibiotic (penicillin-streptomycin). The HEp2 cells were also purchased from ATCC and maintained in a 50:50 mixture of DMEM/AMEM supplemented with 5% FBS and Primocin antibiotic. The hCMEC/D3 cells were obtained from Dr. Pierre-Olivier Couraud from Institut COCHIN in Paris (France). All other reagents were purchased from Life Technologies. 
Dark Cytotoxicity-
A 32 mM compound stock solution was prepared by dissolving the
Microscopy-Human
HEp2 cells were incubated in a six-well plate (MatTek) and allowed to grow overnight. The cells were exposed to 10 μM of each BODIPY and incubated for 6 h (37 °C, 95% humidity, 5% CO 2 ), followed by the addition of organelle tracers obtained from Invitrogen. The organelle tracers were used at the following concentrations: LysoSensor Green, 50 nM; MitoTracker Green, 250 nM; ER Tracker Blue/ White, 100 nM; and BODIPY FL C5 Ceramide, 50 nM. The cells were incubated with the BODIPY and tracers for 30 min and washed with PBS three times before imaging. The images were acquired using a Leica DMRXA2 upright microscope with a water immersion objective and DAPI, GFP, and Texas Red filter cubes (Chroma Technologies).
hCMEC/D3 Cell Line (BBB Model)-
The BBB permeabilities were determined following a published procedure. 32 , 33 Specifically, the hCMEC/D3 cells were incubated in a six-well, 0.4 μm porosity PET Transwell plate (Corning) for 48 h, allowing the formation of a model brain capillary endothelial monolayer (checked by microscopy). EBM-2 medium containing 5% FBS, 1% penicillin/streptomycin, hydrocortisone, ascorbic acid, chemically defined lipid concentrate (1/100), HEPES, and bFGF was used as the growth medium. The coated PET Transwell plates with and without endothelial cells were transferred into sixwell plates. The measurements were performed in triplicate for each compound, using three PET Transwell plates with cells and three without cells. The time points of the treatment were 0, 10, 25, and 45 min. At time 0, a 0.5 mL sample of each BODIPY or standard lucifer yellow (LY) at 50 μM concentration in transport buffer was added to the upper chamber (mimicking the blood), and 1.5 mL of transport buffer was added to the lower chamber (mimicking the BBB); see Figure S24 in the Supporting Information. The transport buffer was prepared by adding 5 mL of HEPES (1 M) and 5 mL of sodium pyruvate (100 μM) to 400 mL of HBSS. The plates were incubated at 37 °C, 95% humidity, and 5% CO 2 . At time 10 and 25 min, each upper PET Transwell was transferred to the corresponding prepared sixwell plate containing 1.5 mL of transport buffer: the so-called "25 min" first and then the "45 min". At each time point, solution in the lower chamber was added into a 96-well plate with 100 μL for each well (five wells). The fluorescence intensity of the solution was measured by using a BMG FLUOstar plate reader at 485/590 nm and 425/538 nm (excitation/emission) for BODIPYs and LY, respectively, and the concentrations were determined from the corresponding standard curves. The calculations of permeability coefficients (P e , in cm/s) were performed following the clearance principle as described in the equations below (eqs 1 and 2), where X is the amount of sample in the lower chamber and Cd is the concentration of sample in the upper chamber at each time point. The total cleared volume at each time point is calculated by summing the incremental cleared volumes up to the given time point.
(1)
The cleared volume is plotted vs time, and a linear fit is applied. (2) where PSt is the slope of the clearance curve for the culture, PSf is the slope of the clearance curve with the control Transwell plate without cells, and A is the surface area of the PET Transwell plate.
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Synthesis and Characterization
A series of seven carboranyl-BODIPYs 1b, 2b, 3b, 20 4, 5b, 6b, and 7, 27 five of which are new, were synthesized as shown in Scheme 1. The key chloro-BODIPY starting materials were synthesized from the corresponding dipyrroketones, as previously reported. 26 , 27 , 29 The ortho-carborane cluster was chosen as the boron source because of its high boron content, high hydrophobicity, high stability under physiologic conditions, and low toxicity. 7 , 11 8-Chloro-BODIPYs 1a-3a and 5a were converted into their corresponding 8-carboranylthioBODIPYs by reaction with 1.1 equiv of 1-mercapto-o-carborane in THF at room temperature, in yields ranging from 88% to 95%. We have previously reported that 3,8-dichloro-BODIPY 6a undergoes highly regioselective substitutions at the 8-position in the presence of N-and O-centered nucleophiles. 27 Using more reactive S-nucleophiles, the 8-vs 3-substitution regioselectivity tends to decrease. However, due to the electron-withdrawing nature of the carborane cluster, BODIPY 6a reacted smoothly with 1.1 equiv of 1-mercaptoo-carborane, affording 6b with high regioselectvity in 74% yield. On the other hand, BODIPY 7 was prepared from 6a via two successive regioselective reactions, a Stille crosscoupling at the 8-position using 1 equiv of tributylphenylstannane and Pd(PPh 3 ) 4 , followed by substitution using an excess of 1-mercapto-o-carborane, as we have previously reported. 27 The Suzuki cross-coupling reaction of BODIPY 1a with 1.5 equiv of 4-(1-methyl-o-carborane)-methylphenylboronic acid in toluene and in the presence of Pd(PPh 3 ) 4 and 1 M Na 2 CO 3 (aq) produced BODIPY 4 in 45% isolated yield.
The structures of the new BODIPYs 1b, 2b, 5b, 6b, and 4 were confirmed by 1 H, 13 C, and 11 B NMR, HRMS and in the cases of 2b and 5b by X-ray crystallography (Figure 1) . We have previously reported the X-ray structures of 3b 20 and 7. 27 Crystals of BODIPYs 2b
and 5b suitable for X-ray analysis were obtained by slow diffusion of hexanes into chloroform ( Figure 1 ). In 2b, the B atom of the central C 3 N 2 B ring lies slightly (0.214 Å) out of the plane of the other five atoms, which are fairly coplanar, having a mean deviation of 0.013 Å. The carborane lies on the bisector of this plane, with C-C-S-C torsion angle 93.9°. In 5b, the central ring is slightly more planar, with the 8-C atom lying 0.098 Å out of the C 2 N 2 B plane. The S atom lies 0.319 Å out of this plane, and as in 2b, the carborane lies on the bisector, with C-S-C-C torsion angle of 94.1°. The ethyl group is also approximately perpendicular to the ring system, with C-C-CH 2 -CH 3 torsion angle of 83.7°.
The spectroscopic properties of all BODIPYs in dichloromethane solution were investigated, and the results are summarized in Table 1 (see also Figures S32-S44 of the Supporting Information). The absorption spectra of all BODIPYs followed the Lambert-Beer law, indicative of no aggregation in this solvent at the concentrations tested. The introduction of an ortho-carboranylthio group at the meso(8)-position in BODIPYs 1b-3b, 5b, and 6b
caused large red-shifts on the maximum absorption (up to 57 nm) and emission (up to 73 nm) bands. This is probably due to the stabilization of the LUMO by this group, which decreases the HOMO-LUMO gap. 34 On the other hand, introduction of the same group at the α(5)-position, as in BODIPY 7, induced a slight blue-shift (~5 nm) relative to the starting BODIPY 6a. 27 Arylation at the 8-position, as in BODIPY 4, also produced a slight blue-shift compared with the starting 8-chloro-BODIPY 1a probably due to a large dihedral angle between the aryl group and the BODIPY core. The fluorescence quantum yields were higher for BODIPY 1b, suggesting low rotational freedom for the 8-carboranylthio group, and it decreased with increasing alkyl substitution for 2b, 3b, and 5b. This is attributed to increased energy lost to nonradiative deactivation processes. 27 , 34 On the other hand, BODIPY 4 shows much lower quantum yield than 7, probably due to the higher rotation of the 8-aryl group in the absence of 1,7-methyl groups.
Cytotoxicity and Uptake in T98G Cells
The cytotoxicity (dark and light, using 1.5 J/cm 2 light dose) and time-dependent uptake of all carboranyl-BODIPYs were investigated in human glioma T98G cells, and the results are summarized in Table 2 and Figure 2 (see also Figures S25 and S26 in the Supporting Information). The IC 50 values were calculated from dose-response curves. This is the first report on the cytotoxicity and cellular uptake of carborane-containing BODIPYs.
None of the BODIPYs, with the exception of 5b, showed any toxicity in the dark at concentrations up to 100 μM, as shown in Supporting Information, Figure S25 . Upon irradiation with light, some BODIPYs showed enhanced cytotoxicity (see Supporting Information Figure S26 ), namely, 5b with calculated IC 50 = 40 μM and 3b with calculated IC 50 = 80 μM; for all other BODIPYs the IC 50 values were above 98 μM. The higher phototoxicity observed for 5b might be a result of its higher uptake by T98G cells, as shown in Figure 2 . Indeed, 5b accumulated the most within cells at all the time points investigated, while 7 accumulated the least, among this series of BODIPYs. The very low uptake observed for BODIPY 7 is probably due to its poor aqueous solubility. The lipophilic character of this series of BODIPYs was evaluated by determining their distribution between 1-octanol and water, and the values obtained for the partition coefficients (log P) are given in Table 2 . The extent of cellular uptake did not correlate with the hydrophobic character of the BODIPYs, which increased in the order 1b < 2b < 3b < 5b ~ 6b < 4 ≪ 7. With the exception of 7, all compounds were taken up rapidly in the first 2 h after which slower uptake was observed for all compounds except for 1b where a plateau was reached. After 24 h, the amount of compound accumulated within cells varied considerably (Table 2) ; compound 5b showed the highest uptake, about 436-fold higher than 7, followed by 6b (135-fold higher than 7), 4 (118-fold higher than 7), 2b (106-fold higher than 7), 1b (67-fold higher than 7), and 3b (33-fold higher than 7). These results indicate that among this series of compounds, BODIPY 5b could deliver the largest and therapeutic amount of boron within glioma cells, with very low dark toxicity.
To investigate the sites of subcellular localization of the carboranyl-BODIPYs, HEp2 rather than T98G cells were used for fluorescence microscopy, as the HEp2 cells facilitate imaging by nicely spreading on the surface of the six-well plate. The organelle-specific probes BODIPY Ceramide (Golgi), LysoSensor Green (lysosomes), MitoTracker Green (mitochondria), and ER Tracker Blue/White (endoplasmic reticulum) were used in the overlay experiments. The results are shown in Figures 3 and 4 for BODIPYs 1b and 5b, respectively (see also Supporting Information, Figures S27-S31 ). All carboranyl-BODIPYs localized preferentially in the cell ER, as shown in Figures 3d and 4d . In addition, the BODIPYs were also observed, but to a smaller extent, in the lysosomes, mitochondria, and Golgi apparatus. These results are in agreement with previous studies showing preferential ER-localization for BODIPY molecules.
BBB Permeability
The hCMEC/D3 cell line is a useful model for studies of BBB permeability because it retains many of the morphological and functional characteristics of human brain endothelial cells. 17 -19 , 33 We have recently used this model to investigate the BBB permeability of a series of carboranylporphyrins 16 and BODIPYs. 20 All compounds of these types tested to date showed low permeability values (P e < 3 × 10 −6 cm/s) with exception of BODIPY 3b 20 which showed higher permeability (P e = 4 × 10 −5 cm/s) than LY. This was attributed to its smaller MW and lower hydrophobic character among the compounds tested. In this study we evaluated a new series of derivatives of 3b (MW = 422, log P = 1.7), with MW and hydrophobic character in the ranges 366-527 Da and 1.5-2.7, respectively, chosen to favor BBB and tumor cell permeability. For comparison purposes and for evaluation of the cell monolayer integrity, we also determined the BBB permeability for LY, a polar fluorescent molecule with MW in the same range (457.24 Da) as the BODIPYs. The results obtained are shown in Table 2 . The P e values could not be determined for 4 and 7, due to their poor solubility in buffer, which caused these compounds to precipitate. All carboranyl-BODIPYs tested showed higher BBB permeability compared with LY, a marker for low BBB permeability. Among this series of compounds, 1b showed the highest P e value (7-fold higher than LY), maybe due to its lower MW (366 Da) and favorable hydrophobic character (log P = 1.50), conferring it the highest solubility in buffer as well as lipophilicity. Compound 2b, of similar MW (394 Da) and hydrophobicity (log P = 1.69) to 1b, showed the second highest P e value. The other BODIPYs, including 3b, with increased alkyl and/or aryl substitution, MW > 400 Da, and log P > 1.7, showed lower P e values although still higher than that determined for LY. Compound 5b showed the lowest P e value among this series of BODIPYs, slightly higher than LY, and therefore is considered to have low BBB permeability, although it was the most efficiently taken up by the T98 glioma cells ( Figure  2 ). All other BODIPYs display BBB permeabilities higher than that reported for phenytoin, which has been used as a marker for medium BBB permeability. 33 , 35 Among the new dichloromethane in the range 0.6-0.03. All BODIPYs showed low dark toxicity (IC 50 > 100 μM) in human glioma T98G cells, an important property of potential boron delivery agents because of the high boron concentration requirement in BNCT (>20 μg/g tumor). The BODIPYs also showed low phototoxicity (IC 50 > 80 μM) with the exception of 5b (IC 50 = 40 μM), probably as a result of its remarkably high uptake into T98G glioma cells. On the other hand, BODIPY 1b showed the largest permeability across the BBB model consisting of hCMEC/D3 cells. Our results show that the BODIPYs with MW < 400 Da and log P < 1.7 are the most efficient at crossing the BBB model. The most hydrophobic compound 7 (log P = 2.7) was poorly soluble in aqueous solutions, showed very low uptake into T98G cells, and its precipitation in buffer precluded determination of its BBB permeability. All BODIPYs tested showed higher BBB permeability compared with LY, as well as low dark cytoxicity and therefore could potentially be efficient boron delivery agents for BNCT of brain tumors. Among this series, 1b and 2b showed the highest BBB permeability while 5b and 6b accumulated the most within tumor cells; therefore, these are the most promising BNCT agents.
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